FuelPositive Corp.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA35954F1080
CAD
0.07
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About FuelPositive Corp. stock-summary
stock-summary
FuelPositive Corp.
Pharmaceuticals & Biotechnology
EEStor Corporation is a Canada-based development-stage company. The Company is focused on providing electrical energy storage and related capacitor technologies. It focuses on the development of electrical energy storage unit (EESU) and High Voltage Capacitor Technology. The Company focuses on licensing opportunities across a spectrum of industries and applications. The Company holds approximately 70% equity and voting interest to a solid-state capacitor and related energy storage technologies under development by EEStor Inc. In addition, it also focuses on advanced polymer program to further the Company's capacitor technology into higher energy density applications. It focuses on enabling other equipment manufacturer (OEM) and other partners to deliver electric transportation solutions to their customers. Its subsidiaries include EEStor Limited, ZENN Capital Inc., ZENNergy Inc., ZMC America, Inc. and EEStor Inc. The Company has not generated any revenue.
Company Coordinates stock-summary
Company Details
82 Richmond Street East , TORONTO CA : M5C 1P1
stock-summary
Tel: 1 416 5358395
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Ian Clifford
Chief Executive Officer, Director
Mr. Noel Cuesta
Director
Dr. Robert Tocchio
Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-1 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CAD 39 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.02

stock-summary
Return on Equity

-43.88%

stock-summary
Price to Book

2.67